News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research
Alamar Biosciences launches NULISAqpcr™ BD-pTau217 Assay, a breakthrough in non-invasive, brain-specific biomarker detection for Alzheimer's disease research. The assay offers unparalleled sensitivity and CNS specificity, redefining biomarker quantitation